The U.S. HSV testing market size was estimated at USD 205.0 million in 2024 and is expected to grow at a CAGR of 5.24% from 2025 to 2033. The market includes a range of diagnostic solutions designed for the accurate and timely detection of herpes simplex virus types 1 and 2. Testing meth... Read More »
August 2025The Asia Pacific oncology based molecular diagnostics market size was estimated at USD 822.5 million in 2024 and is projected to reach USD 1,560.75 million by 2033, growing at a CAGR of 6.8% from 2025 to 2033. Rising cancer burden across breast, prostate, and colon, along with the aging ... Read More »
August 2025The global molecular diagnostics in pharmacogenomics market size was valued at USD 699.7 million in 2024 and is projected to grow from USD 784.6 million in 2026 to USD 1, 256.4 million by 2033, at a CAGR of 6.8% from 2025 to 2033. North America dominated the market, accounting for a reve... Read More »
August 2025The U.S. allergy and autoimmune disease diagnostics market size was estimated at USD 4.03 billion in 2024 and is projected to reach USD 8.40 billion by 2033, growing at a CAGR of 8.67% from 2025 to 2033. The market is primarily driven by the rising incidence of allergic and autoimmune di... Read More »
August 2025The U.S. point of care molecular diagnostics market size was estimated at USD 3.23 billion in 2024 and is expected to grow at a CAGR of 5.45% from 2025 to 2033. The market is centered around rapid and decentralized molecular testing that supports quicker clinical decisions at or near the... Read More »
July 2025The global HSV testing market size was valued at USD 611.97 million in 2024 and is projected to grow from USD 672.03 million in 2026 to USD 1,017.75 million by 2033, at a CAGR of 6.0% from 2025 to 2033. This market encompasses diagnostic solutions aimed at the timely and reliable de... Read More »
July 2025The U.S. pharmaceutical sterility testing market size was estimated at USD 0.67 billion in 2024 and is projected to reach USD 1.70 billion by 2033, growing at a CAGR of 11.04% from 2025 to 2033. The market is driven by increasing R&D activities, growing dr... Read More »
July 2025The global liquid biopsy for early cancer detection and monitoring market size was valued at USD 2.2 billion in 2024 and is projected to grow from USD 2.8 billion in 2026 to USD 6.2 billion by 2033, at a CAGR of 12.1% from 2025 to 2033. North America dominated the market, accounting for ... Read More »
July 2025The U.S. ATP assays market size was estimated at USD 1.10 billion in 2024 and is projected to register a CAGR of around 3.87% through 2033. The market is primarily driven by increasing demand for rapid, reliable testing methods across drug discovery, clinical diagnostics, environmental m... Read More »
July 2025The global allergy and autoimmune disease diagnostics market size was valued at USD 11.4 billion in 2024 and is projected to grow from USD 13.2 billion in 2026 to USD 25.0 billion by 2033, at a CAGR of 5.4% from 2025 to 2033. North America dominated the market, accounting for a revenue s... Read More »
July 2025The U.S. prostate cancer biomarkers market size was estimated at USD 1.7 billion in 2024 and is expected to grow at a CAGR of 14.74% from 2025 to 2033. The market growth is driven by the rising prevalence of prostate cancer, awareness around early detection, and adoption of precision dia... Read More »
July 2025The U.S. clinical laboratory services market size was estimated at USD 9.42 billion in 2024 and is projected to register a CAGR of 5.07% from 2025 to 2033. The market is primarily driven by the increasing burden of chronic diseases, which has intensified the demand for routine and specia... Read More »
July 2025The U.S. microarray market size was estimated at USD 2.65 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2033. The market is driven by the surging demand for personalized medicine, especially in precision oncology and pharmacogenomics. With rising investments fro... Read More »
July 2025The global hemato oncology testing market size was estimated at USD 3.60 billion in 2024 and is projected to reach USD 7.44 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. Hemato oncology is associated with the treatment, diagnosis, and prevention of blood-related cancers... Read More »
July 2025The China Alzheimer’s disease diagnostics market was estimated at USD 319.6 million in 2024 and is projected to reach USD 617.8 million by 2030, growing at a CAGR of 11.7% from 2025 to 2030. The increasing prevalence of Alzheimer’s disease (AD), growing adoption of personaliz... Read More »
July 2025The global blood-based biomarker for parkinson’s disease market size was valued at USD 117.8 million in 2024 and is projected to grow from USD 174.2 million in 2026 to USD 350.9 million by 2033, at a CAGR of 19.3% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 43.3% in... Read More »
July 2025The U.S. anatomic pathology market size was estimated at USD 9.71 billion in 2024 and is projected to reach USD 15.35 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. This market is experiencing robust growth driven by technological innovation and growing clinical demands.... Read More »
July 2025The U.S. blood-based biomarker for parkinson’s disease market size was estimated at USD 45.75 million in 2024, and is projected to grow at a CAGR of 18.33% from 2025 to 2033. The U.S. Parkinson’s disease (PD) blood-based biomarkers market is driven by a growing patient popula... Read More »
July 2025The U.S. ferritin testing market size was estimated at USD 274.60 million in 2024 and is projected to grow at a CAGR of 5.63% from 2025 to 2033. The market is driven by the rising prevalence of iron deficiency anemia and related chronic conditions such as inflammatory diseases, chronic k... Read More »
July 2025The global point of care drug of abuse testing market size was valued at USD 1.1 billion in 2024 and is projected to grow from USD 1.3 billion in 2026 to USD 2.5 billion by 2033, at a CAGR of 9.6% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 39... Read More »
July 2025